Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Pro…
뉴스와이어신상품
0
33
0
4시간전
INCHEON, Korea--(Business Wire/Korea Newswire)--Samsung Bioepis Co., Ltd. today announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in...
